400-859-2883
Your location:Home >News center >Industry News

Industry News

11-202021

What Are PEG Linkers and Their Applicatio…

Learn more detailes about PEG linkers and its applications in pharmaceutical field.

What Are PEG Linkers and Their Applications?
11-162021

Ten Most Popular Anti-cancer Drugs In 202…

In view of the complexity of cancer treatment and peoples needs, the market prospects of anti-tumor drugs are broad. Many pharmaceutical and biotechnology companies have stepped up research a…

Ten Most Popular Anti-cancer Drugs In 2021
11-112021

Type 2 Diabetes Patients May Expect Remis…

There is no cure for type 2 diabetes, but weight loss, healthy eating, and exercise can help people manage the disease. If diet and exercise are not enough to control blood sugar, the diabete…

Type 2 Diabetes Patients May Expect Remission From Short Term Low Carbohydrate Diet
09-022021

Increased Vitamin D Intake May Protect Ag…

Recent studies in this cohort have confirmed a significant association between sedentary & obesity and an increased risk of early-onset colorectal cancer, indicating that at least some we…

Increased Vitamin D Intake May Protect Against Early-onset Colorectal Cancer
08-282021

Antibody-Drug Conjugates for Cancer Thera…

Antibody-drug conjugates (ADCs) are a rapidly evolving class of anticancer therapeutics consisting of antibodies attached to potent cytotoxic drugs via chemical linkers.

Antibody-Drug Conjugates for Cancer Therapy - Prospects and Challenges
08-182021

FDA Accelerates Approval of GSK PD-1 Anti…

On August 17, GlaxoSmithKline plc (GSK) announced that the U.S. Food and Drug Administration (FDA) has accelerated the approval of its PD-1 antibody Jemperli (dostarlimab-gxly) for extended i…

FDA Accelerates Approval of GSK PD-1 Antibody To Treat dMMR Solid Tumors